Daniele Vallisa
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 33
-
- Lymphoma Diagnosis and Treatment 40
- Oncology top 5%
- Viral-associated cancers and disorders 14
- Internal Medicine top 10%
-
- Ovarian cancer diagnosis and treatment 7
-
- Chronic Myeloid Leukemia Treatments 7
-
- CNS Lymphoma Diagnosis and Treatment 6
-
- Central Venous Catheters and Hemodialysis 4
- Co-authors
- Luigi CavannaElisabetta BuscariniLuigi BuscariniRaffaella BertèAndrea RoccaM. StasiGiuseppe CivardiPietro Quaretti
- Partner nations
- ItalyUkraineUnited Kingdom
In The Last Decade
Daniele Vallisa
90 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 92
- Hepatology 585
- Genetics 506
- Pathology and Forensic Medicine 692
- Oncology 727
- Internal Medicine 53
Countries citing papers authored by Daniele Vallisa
This map shows the geographic impact of Daniele Vallisa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Vallisa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Vallisa more than expected).
Fields of papers citing papers by Daniele Vallisa
This network shows the impact of papers produced by Daniele Vallisa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Vallisa. The network helps show where Daniele Vallisa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniele Vallisa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 9 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 36 | |
| 7 | 2015 | 1 | |
| 8 | 2015 | 4 | |
| 9 | 2015 | 22 | |
| 10 | 2011 | 52 | |
| 11 | 2009 | 42 | |
| 12 | 2007 | 19 | |
| 13 | 2002 | 22 | |
| 14 | Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma. | 2001 | 62 |
| 15 | 2001 | 2 | |
| 16 | Percutaneous radiofrequency ablation of small hepatocellular carcinoma. Long term results | 2000 | 2 |
| 17 | Primary lymphoma of the spleen. Report of a case with diagnosis by fine-needle guided biopsy. | 1995 | 14 |
| 18 | 1995 | 16 | |
| 19 | 1994 | 20 | |
| 20 | 1992 | 46 |
About Daniele Vallisa
Daniele Vallisa is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 96 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (40 papers), Chronic Lymphocytic Leukemia Research (33 papers), Viral-associated cancers and disorders (14 papers), Ovarian cancer diagnosis and treatment (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Central Venous Catheters and Hemodialysis (4 papers). The work is most often cited by research in Hepatology (585 citations), Genetics (506 citations) and Pathology and Forensic Medicine (692 citations). Daniele Vallisa has collaborated with scholars based in Italy, Ukraine and United Kingdom. Frequent co-authors include Luigi Cavanna, Elisabetta Buscarini, Luigi Buscarini, Raffaella Bertè, Andrea Rocca, M. Stasi, Giuseppe Civardi, Pietro Quaretti, Antonio Lazzaro and Patrizia Bernuzzi. Their work appears in journals such as Blood, Cancer, European Journal of Cancer, Acta Haematologica and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.